Hostname: page-component-5447f9dfdb-tm5m8 Total loading time: 0 Render date: 2025-07-28T22:27:57.327Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Trials with Melleril (TP21) in the Treatment of Schizophrenia

A Two-Year Study

Published online by Cambridge University Press:  08 February 2018

R. A. Sandison ,
Eileen Whitelaw  and
J. D. C. Currie
R. A. Sandison
Affiliation:
Powick Hospital, near Worcester
Eileen Whitelaw
Affiliation:
Powick Hospital, near Worcester
J. D. C. Currie
Affiliation:
Powick Hospital, near Worcester
Get access Rights & Permissions [Opens in a new window]

Extract

The authors undertook to investigate the effects of two new phenothiazine derivatives on schizophrenic patients. Over a period of two years a series of clinical trials have been carried out on approximately 260 patients, some controlled, some uncontrolled. These drugs, known as Melleril (TP21) and KS75 are chemically related. Although Melleril was ultimately selected as the drug of choice we have, for statistical reasons, included some of the findings with KS75.

Information

Type
Original Articles
Information
Journal of Mental Science , Volume 106 , Issue 443 , April 1960 , pp. 732 - 741
Copyright
Copyright © Royal College of Psychiatrists, 1960 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Taeschler, M., and Cerletti, A., “Zur Pharmakologie von Thioridazin, Melleril”, Schweiz. Med. Wschr., 1958, 48, 1216.Google Scholar
Iidem , “Differential analysis of the effects of phenothiazine-tranquillizers on emotional and motor behaviour in experimental animals”, Nature, 1959, 12 September, 823.CrossRefGoogle Scholar
Foulds, G. A., “Clinical research in psychiatry”, J. Ment. Sci., 1958, 104, 259.CrossRefGoogle Scholar
Cohen, S., “TP 21, a new phenothiazine”, Amer. J. Psychiat., 1958, 115, 358.Google Scholar
Hollister, L. E., and MacDonald, B. F., “Thioridazine (Melleril) in psychiatric patients”. Paper presented at annual meeting of California Medical Association; Section on Psychiatry, San Francisco, 25 February, 1959. To be published.Google Scholar
Fleeson, W., Glueck, B., Heistad, G., King, J. E., Lykken, D., Meekl, P., and Mesia, A., “The ataraxic effect of two phenothiazine drugs on an out-patient population”, Univ. Minnesota Med. Bull., 1958, 29, 274.Google Scholar
Kinross-Wright, V., “Newer phenothiazine drugs in the treatment of nervous disorders”, J. Amer. Med. Ass., 1959, 170, 1283.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.